Skip to content

Veracyte VCYT Accounts Payable

Accounts Payable at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$62.4M+59.0%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$133.1M-3.5%
Revvity logo
RevvityRVTY
$169.68M-4.7%
Labcorp Holdings logo
Labcorp HoldingsLH
$695.7M-3.1%
Quest Diagnostics logo
Quest DiagnosticsDGX
$1.5B+18.4%
Agilent Technologies logo
Agilent TechnologiesA
$615M+19.0%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's accounts payable?
Veracyte (VCYT) reported accounts payable of $6.91M in Q1 2026.
How has Veracyte's accounts payable changed year-over-year?
Veracyte's accounts payable decreased by 56.0% year-over-year, from $15.71M to $6.91M.
What is the long-term trend for Veracyte's accounts payable?
Over 5 years (2020 to 2025), Veracyte's accounts payable has grown at a 8.1% compound annual growth rate (CAGR), from $3.12M to $4.59M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.